Getty ImagesNEW DELHI: Shares of Ltd. traded 0.92 per cent up in Tuesday's trade at 12:09PM (IST). Around 50,916 shares changed hands on the counter.
The counter opened at Rs 970.1 and touched an intraday high and low of Rs 979.5 and Rs 963.45, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 737.9.
As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 57175.89 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 6079.6 crore for the quarter ended 31-Mar-2021, down 6.44 per cent from previous quarter's Rs 6498.31 crore and down 1.8 per cent from the year-ago quarter's Rs 6191.02 crore.
The net profit for latest quarter stood at Rs 801.58 crore, down 5.68 per cent from the corresponding quarter last year.
Shareholding pattern
As of 31-Mar-2021, domestic institutional investors held 8.84 per cent stake in the company, while foreign institutional investors held 24.37 per cent and the promoters 48.86 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 10.72 and a price-to-book ratio of 1.44. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
The counter opened at Rs 970.1 and touched an intraday high and low of Rs 979.5 and Rs 963.45, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 737.9.
As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 57175.89 crore at the time of writing this report.
Did you Know?
Stock score of Aurobindo Pharma Ltd moved down by 3 in a month on a 10-point scale.
View Latest Stock Report »Key Financials
The company reported consolidated net sales of Rs 6079.6 crore for the quarter ended 31-Mar-2021, down 6.44 per cent from previous quarter's Rs 6498.31 crore and down 1.8 per cent from the year-ago quarter's Rs 6191.02 crore.
The net profit for latest quarter stood at Rs 801.58 crore, down 5.68 per cent from the corresponding quarter last year.
Shareholding pattern
As of 31-Mar-2021, domestic institutional investors held 8.84 per cent stake in the company, while foreign institutional investors held 24.37 per cent and the promoters 48.86 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 10.72 and a price-to-book ratio of 1.44. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.